Probiotec Ltd
ASX:PBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
WA1 Resources Ltd
ASX:WA1
|
AU |
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
iCollege Ltd
ASX:ICT
|
AU |
|
Zee Media Corporation Ltd
NSE:ZEEMEDIA
|
IN |
|
DICK'S Sporting Goods Inc
NYSE:DKS
|
US |
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
CN |
|
White Energy Company Ltd
ASX:WEC
|
AU |
|
VEEM Ltd
ASX:VEE
|
AU |
|
Rts Power Corporation Ltd
BSE:531215
|
IN |
|
P
|
Pure Hydrogen Corporation Ltd
OTC:PHCLF
|
AU |
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| AU |
|
Probiotec Ltd
ASX:PBP
|
242.3m AUD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD |
Loading...
|
Market Distribution
| Min | -16 177 900% |
| 30th Percentile | -544.7% |
| Median | -27.7% |
| 70th Percentile | 3.1% |
| Max | 3 174 540% |
Other Profitability Ratios
Probiotec Ltd
Glance View
Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-11-14. The firm owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. The Company’s products are manufactured on behalf of a range of clients, including international companies. The company also owns Multipack-LJM business, a contract packer, providing packing services for a range of pharmaceutical, consumer healthcare, cosmetics and food, and beverage companies. The firm subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Biotech Pharmaceuticals Australia Pty Ltd, Biotech Pharmaceuticals Pty Ltd, Probiotec (NSW) Pty Ltd, Australian Dairy Proteins Pty Ltd, Milton Pharmaceuticals Pty Ltd and Willie Labs Generics Pty Ltd.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Probiotec Ltd is 3.9%, which is below its 3-year median of 4.5%.
Over the last 3 years, Probiotec Ltd’s Net Margin has increased from 3.8% to 3.9%. During this period, it reached a low of 3.8% on Dec 31, 2020 and a high of 7.5% on Jun 30, 2022.
